This article examines key innovations driving scalable, high-yield purification of recombinant AAVs and how they’re helping ...
Opportunities in viral vector manufacturing arise from rising demand for GMP-grade materials and increasing gene therapy ...
FutureWise Research, a leading global market intelligence firm, today released a landmark report on Plasmid DNA Manufacturing ...
OXB, formerly known as Oxford BioMedica, is expanding in a heartland of the US life science marketplace through the purchase ...
Receiving a platform technology designation from the FDA is a tremendous milestone for our development team and Krystal, both as recognition of the reproducibility and scalability of our HSV-1 gene ...
Thermo Fisher will equip Dr. Park CDMO’s new facility with advanced bioreactors to scale viral vector manufacturing.
Headlines: Xevo CDMS facilitates direct, accurate mass detection for the largest, most heterogeneous biomolecules.1 Enables ...
Partners will advance end-to-end development of biologics for regionally prioritized diseases starting with Mpox and HIV CAIRO, EGYPT; BERLIN, GERMANY; AND NEW YORK, NY / ACCESS Newswire / October 10, ...
OXB acquires Resilience’s site in North Carolina, an FDA-approved, commercial-scale viral vector manufacturing facility In line with OXB’s previously announced strategy to add US GMP capacity across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback